Results 31 to 40 of about 151,232 (337)

Spontaneous iliopsoas muscle hematoma in a patient with von Willebrand disease: a case report

open access: yesJournal of Medical Case Reports, 2011
Introduction Iliopsoas hemorrhage is a serious complication of bleeding disorders that occurs most commonly in patients with hemophilia and less commonly in patients with von Willebrand disease.
Soltani Shirazi Ahmad, Keikhaei Bijan
doaj   +1 more source

Case report: A case of acquired von Willebrand syndrome as onset clinical presentation of systemic lupus erythematosus manifested as epistaxis and pulmonary hemorrhage

open access: yesFrontiers in Pediatrics, 2022
BackgroundAcquired von Willebrand syndrome (AVWS) is a less common bleeding disorder, primarily manifested as mild to moderate mucocutaneous bleeding and laboratory tests are similar to hereditary von Willebrand disease (VWD).
Songmi Wang   +6 more
doaj   +1 more source

Doença de von Willebrand e anestesia Enfermedad de von Willebrand y anestesia Von Willebrand's disease and anesthesia

open access: yesRevista Brasileira de Anestesiologia, 2007
JUSTIFICATIVA E OBJETIVOS: A doença de von Willebrand ocorre devido à mutação no cromossomo 12 e é caracterizada por deficiência qualitativa ou quantitativa do fator de von Willebrand.
Fabiano Timbó Barbosa   +2 more
doaj   +1 more source

Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies.

open access: yesBlood Advances, 2019
Type 3 von Willebrand disease with alloantibodies is a rare clinical entity with few treatment options. Emicizumab prophylaxis in such patients may result in improved hemarthrosis control, lower cost, and enhanced quality of life.
A. Weyand, V. Flood, J. Shavit, S. Pipe
semanticscholar   +1 more source

An international survey to inform priorities for new guidelines on von Willebrand disease

open access: yesHaemophilia, 2019
von Willebrand disease (VWD) is an inherited bleeding disorder caused by a quantitative or qualitative dysfunction of von Willebrand factor. Clinicians, patients and other stakeholders have many questions about the diagnosis and management of the disease.
Mohamad A. Kalot   +6 more
semanticscholar   +1 more source

Platelet-independent adhesion of calcium-loaded erythrocytes to von Willebrand factor. [PDF]

open access: yesPLoS ONE, 2017
Adhesion of erythrocytes to endothelial cells lining the vascular wall can cause vaso-occlusive events that impair blood flow which in turn may result in ischemia and tissue damage.
Michel W J Smeets   +7 more
doaj   +1 more source

von Willebrand Disease

open access: yesMedicine, 1997
Considerable progress has been made in characterizing the specific molecular defects responsible for the heterogeneous disorder known as von Willebrand disease (VWD). A large number of molecular defects have been identified and precise characterization may now be possible in the majority of type 2A, type 2B, type 2N, and potentially also type 3 VWD ...
W C, Nichols, D, Ginsburg
openaire   +2 more sources

Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders

open access: yesJournal of Clinical Medicine, 2017
Along with haemophilia A and B, von Willebrand disease (VWD) and rare bleeding disorders (RBDs) cover all inherited bleeding disorders of coagulation. Bleeding tendency, which can range from extremely severe to mild, is the common symptom.
G. Castaman, S. Linari
semanticscholar   +1 more source

Treatment of Von Willebrand Disease [PDF]

open access: yesThrombosis and Haemostasis, 1998
SummaryIn von Willebrand disease, there are two main options for the treatment of spontaneous bleeding episodes and for bleeding prophylaxis: desmopressin and transfusional therapy with plasma products. Desmopressin is the treatment of choice for most patients with type 1, who account for approximately 70 to 80 per cent of all cases with the disease ...
C. A. Lee   +5 more
openaire   +6 more sources

Factor fon Willebrand antigen in endothelium functional state assessment in patients with systemic lupus erythematosus

open access: yesНаучно-практическая ревматология, 2004
Objective. To determine the importance of von Willebrand factor antigen as marker of endotheliae damage at the patients with systemic lupus erythematosus (SLE). Material and methods. 30 women from authentic SLE by criteria ACR, in the age of 20-45 years,
M E Zapryagaeva, E S Mach, A A Baranov
doaj   +1 more source

Home - About - Disclaimer - Privacy